As of 4:00pm ET
| -1.70 / -1.95%|
The 6 analysts offering 12-month price forecasts for Agios Pharmaceuticals Inc have a median target of 90.00, with a high estimate of 115.00 and a low estimate of 77.00. The median estimate represents a +5.52% increase from the last price of 85.29.
The current consensus among 8 polled investment analysts is to Buy stock in Agios Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.